Statements (25)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
immunosuppressant
|
| gptkbp:approvalYear |
2021
|
| gptkbp:approvedBy |
gptkb:FDA
|
| gptkbp:ATCCode |
L04AD05
|
| gptkbp:brand |
gptkb:Lupkynis
|
| gptkbp:CASNumber |
133939-07-6
|
| gptkbp:developedBy |
gptkb:Aurinia_Pharmaceuticals
|
| gptkbp:drugClass |
immunosuppressant
|
| gptkbp:hasMolecularFormula |
C62H111N11O12
|
| https://www.w3.org/2000/01/rdf-schema#label |
voclosporin
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:mechanismOfAction |
inhibits calcineurin
|
| gptkbp:pregnancyCategory |
not recommended
|
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:sideEffect |
gptkb:anemia
diarrhea headache hypertension urinary tract infection decreased glomerular filtration rate |
| gptkbp:synonym |
ISA247
|
| gptkbp:usedFor |
lupus nephritis
|
| gptkbp:bfsParent |
gptkb:Lupkynis
gptkb:L04_Immunosuppressants |
| gptkbp:bfsLayer |
8
|